Document ID: EPA-HQ-RCRA-2007-0932-0460
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2019-02-22T05:00Z

EPA/HQ Summary
                         Site Visit at Inmar/Med-Turn

Attendees

Inmar Participants:
Erica Burwell, Errol Flannery, Matt Golz, Richard Sieg
EPA/HQ Participants:
Kristin Fitzgerald, Brian Knieser, Laura Stanley
Other Participants: 	     Greg Blount, Troutman Sanders
                       Anita Ducca, Healthcare Distribution Association
                       Scott Reisch, Hogan Lovells
                       Nicole Wilkinson, CVS
			     
Date:  October 10, 2017

Location:  Inmar/Med-Turn Forth Worth, TX

Summary

Inmar/Med-Turn hosted staff from EPA HQ to provide a tour of their reverse distribution facility. The facility receives primarily prescription pharmaceuticals from its off-site customers to facilitate manufacturer's credit. Inmar estimates that <10 % of the incoming pharmaceuticals are hazardous waste. The site currently operates as a RCRA large quantity generator (LQG).  The site has received Verified-Accredited Wholesale Distributors (VAWD) accreditation from the National Association of Boards of Pharmacy. It does not redistribute or donate any medications from this location. Although there is another Med-Turn facility in Toronto, Ontario in Canada, the two facilities operate separately and do not have any cross border transportation of pharmaceuticals. 

Following the tour, EPA staff met with the participants to ask questions and to discuss EPA's progress on finalizing the Hazardous Waste Pharmaceuticals Rule.